Discover the latest advancements in pancreatic cancer treatment, including targeted therapies and next-generation sequencing, transforming patient care and outcomes.
Shubham Pant, MD
Shubham Pant, MD, is a professor in the Department of Gastrointestinal (GI) Medical Oncology with a joint appointment in the Department of Investigational Cancer Therapeutics (Phase I Center) at The University of Texas MD Anderson Cancer Center.
Articles by Shubham Pant, MD
Shubham Pant, MD, discusses background on zanidatamab and findings from the HERIZON-BTC-01 trial of the agent for HER2-positive biliary tract cancer treatment.
Latest Updated Articles
Dr Shubham Pant Highlights Progress and Promise in Pancreatic Cancer TreatmentPublished: February 3rd 2026 | Updated: